February 1, 2019 / 9:37 AM / 15 days ago

Indian drugmaker Dr. Reddy's Q3 profit rises 65.3 pct, beats estimates

Feb 1 (Reuters) - Indian generic drugmaker Dr. Reddy’s Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, driven by strong growth in emerging markets.

Third-quarter net profit came in at 5 billion rupees ($70.10 million), compared with 3.03 billion rupees a year earlier, the company said bit.ly/2Rvk10b.

Analysts on average expected the Hyderabad-based company to post a profit of 3.94 billion rupees, according to Refinitiv data. ($1 = 71.3300 Indian rupees)

Reporting by Chandini Monnappa in BENGALURU; Editing by Christopher Cushing

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below